Both IL-4 and IL-13 inhibit the TNF-α and IFN-γ enhanced MDC production in a human keratinocyte cell line, HaCaT cells

Journal of Dermatological Science

Volumn 31, Issue 2, 2003, Pages 111-117

  Xiao, Ting ^a,b   Kagami, Shinji ^a   Saeki, Hidehisa ^a   Sugaya, Makoto ^a   Kakinuma, Takashi ^a   Fujita, Hideki ^a   Yano, Shoichiro ^a   Mitsui, Hiroshi ^a   Torii, Hideshi ^a   Komine, Mayumi ^a   Asahina, Akihiko ^a   Nakamura, Koichiro ^c   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Chemokine; HaCaT cell; Keratinocyte; MDC

Indexed keywords

DEXAMETHASONE; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; RECOMBINANT CYTOKINE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 13; RECOMBINANT INTERLEUKIN 4; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TACROLIMUS; TH1 CYTOKINE; TH2 CYTOKINE; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CALCULATION; CELL CULTURE; CELL LINE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INFLAMMATION; STATISTICAL SIGNIFICANCE; SUPERNATANT;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CELL LINE; CHEMOKINES, CC; CYTOKINES; DEXAMETHASONE; DRUG INTERACTIONS; DRUG SYNERGISM; GENE EXPRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-4; KERATINOCYTES; RNA, MESSENGER; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0037381799     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(02)00149-4     Document Type: Article

References (33)

1. Yoshie O., Imai T., Nomiyama H. Chemokines in immunity. Adv. Immunol. 78:2001;57-109.
2. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:2000;217-242.
3. Sauder D.N. The role of epidermal cytokines in inflammatory skin diseases. J. Invest. Dermatol. 95:1990;27S-28S.
4. Barker J.N., Mitra R.S., Griffiths C.E., Dixit V.M., Nicholoff B.J. Keratinocytes as initiators of inflammation. Lancet. 337:1991;211-214.
5. Vestergaard C., Yoneyama H., Murai M., Nakamura K., Tamaki K., Terashima Y., et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104:1999;1097-1105.
6. Wakugawa M., Nakamura K., Akatsuka M., Nakagawa H., Tamaki K. Interferon-gamma-induced RANTES producing by human keratinocytes is enhanced by IL-1 beta, TNF-alpha, IL-4 and IL-13 and is inhibited by dexamethasone and tacrolimus. Dermatology. 202:2001;239-245.
7. Wakugawa M., Nakamura K., Akatsuka M., Kim S.S., Yamada Y., Kawasaki H., et al. Expression of CC chemokine receptor 3 on human keratinocytes in vivo and in vitro - upregulation by RANTES. J. Dermatol. Sci. 25:2001;229-235.
8. Nomiyama H., Imai T., Kusuda J., Miura R., Callen D.F., Yoshie O. Human chemokine fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13. Cytogenet. Cell Genet. 81:1998;10-11.
9. Imai T., Chantry D., Raport C.J., Wood C.L., Nishimura M., Godiska R., et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273:1998;1764-1768.
10. Imai T., Nagira M., Takagi S., Kakizaki M., Nishimura M., Wang J., et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokine thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 11:1999;81-88.
11. Inngjerdingen M., Damaj B., Maghazachi A.A. Human NK cells express CC chemokine receptor 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J. Immunol. 164:2000;4048-4054.
12. Bochner B.S., Bickel C.A., Taylor M.L., MacGlashan D.W., Gray P.W., Raport C.J., et al. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner. J. Allergy Clin. Immunol. 103:1999;527-532.
13. Bonecchi R., Sozzani S., Stine J.T., Luini W., D'Amico G., Allavena P., et al. Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 response. Blood. 92:1998;2668-2671.
14. Chantry D., Romagnani P., Raport C.J., Wood C.L., Epp A., Romagnani S., et al. Macrophage derived chemokine (MDC) is localized to thymic medullary epithelial cells and is a chemoattractant for CD3+, CD4+, CD8 low thymocytes. Blood. 94:1999;1890-1898.
15. Andrew D.P., Chang M.S., McNinch J., Wathen S.T., Rihanek M., Tseng J., et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 161:1998;5027-5038.
16. Galli G., Chantry D., Annunziato F., Romagnani P., Cosmi L., Lazzeri E., et al. Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. Eur. J. Immunol. 30:2000;204-210.
17. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin. Exp. Immunol. 127:2002;270-273.
18. Rottman J.B., Smith T.L., Ganley K.G., Kikuchi T., Krueger J.G. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alpha beta 7 in the pathogenesis of psoriasis vulgaris. Lab. Invest. 81:2001;335-347.
19. Goebeler M., Trautmann A., Voss A., Brocker E.V., Toksoy A., Gillitzer R. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am. J. Pathol. 158:2001;431-440.
20. Albanesi C., Scarponi C., Sebastiani S., Cavani A., Federici M., Sozzani S., et al. A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases. J. Leukoc. Biol. 70:2001;617-623.
21. Minty A., Chalon P., Derocq J.M., Dumont J.C., Guillemot J.C., Kaghad M., et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 362:1993;248-250.
22. Punnonen J., Aversa G., Cocks B., McKenzie A., Menon S., Zurawski G., et al. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA. 90:1993;3730-3734.
23. Mosmann T., Coffman R. TH1 and TH2 cells: different patterns of lymphocyte secretion lead to different functional properties. Annu. Rev. Immunol. 5:1989;429-459.
24. McKenzie A., Culpepper J., de Waal Malefyt R., Briere F., Punnonen J., Aversa G., et al. Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA. 90:1993;3725-3729.
25. Jacobs M.J., van der Hoek A.E., van Lent P.L., van de Loo F.A., van de Putte L.B., van den Berg W.B. Role of IL-2 and IL-4 in exacerbation of murine antigen-induced arthritis. Immunology. 83:1994;390-396.
26. Ramanathan S., de Kozak Y., Saoudi A., Goureau O., Van der Meide P.H., Druet P., et al. Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J. Immunol. 157:1996;2209-2215.
27. Albanesi C., Scarponi C., Sebastiani S., Cavani A., Federici M., De Pità O., et al. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J. Immunol. 165:2000;1395-1402.
28. Fort M.M., Lesley R., Davidson N.J., Menon S., Brombacher F., Leach M.W., et al. IL-4 exacerbates disease in a Th1 cell transfer model of colitis. J. Immunol. 166:2001;2793-2800.
29. Kakinuma T, Nakamura K, Wakugawa M, Yano S, Saeki H, Torii H, Komine M, Asahina A, Tamaki K, IL-4, but not IL-13, modulate TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10 kDa)/CXCL10 release by TNF-α and IFN-γ in HaCaT cell line. Cytokine 2002;20:1-6.
30. Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J. Allergy Clin. Immunol. 107:2001;535-541.
31. Vestergaard C., Bang B., Gesser B., Yoneyama H., Matsushima K., Larsen C.G. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115:2000;640-646.
32. Horikawa T., Nakayama T., Hikita I., Yamada H., Fujisawa R., Bito T., et al. IFN-γ-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epiderma keratinocytes and their roles in atopic dermatitis. Int. Immunol. 14:2002;767-773.
33. Grewe M., Bruijnzeel-Koomen C.A.F.M., Schöpf E., Thepen T., Langeveld-Wildschut A.G., Ruzicka T., et al. A role for TH1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today. 19:1998;359-361.